Wedzony K, Limberger N, Späth L, Wichmann T, Starke K
Pharmakologisches Institut, Freiburg i.Br., Federal Republic of Germany.
Naunyn Schmiedebergs Arch Pharmacol. 1988 Sep;338(3):250-5. doi: 10.1007/BF00173396.
Experiments in slices of rat nucleus accumbens were carried out in order to investigate whether the release of acetylcholine in this tissue is modulated through dopamine receptors. The slices were preincubated with 3H-choline and then superfused and stimulated electrically twice for 2 min each at a frequency of 3 Hz. The electrically evoked overflow of tritium averaged 2.9-3.9% of the tritium content of the tissue in the various groups. The D2-selective agonist quinpirole (0.01-1 mumol/l) reduced the evoked overflow of tritium by maximally 56%, an effect antagonized by the D2-selective antagonist (-)-sulpiride (1 mumol/l). The D1-selective agonist 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine (SKF 38393) caused a slight decrease only at the high concentration of 10 mumol/l. (-)-Sulpiride (0.1-10 mumol/l) moderately increased the evoked overflow of tritium when given alone. The dopamine uptake inhibitor nomifensine (10 mumol/l) caused a decrease, and in its presence the increase produced by (-)-sulpiride became much more marked, amounting to maximally 149% (+)-Sulpiride (0.1-1 mumol/l) failed to change the evoked overflow of tritium in the presence of nomifensine. The dopamine-releasing agent (+/-)-amphetamine (1 mumol/l) also reduced the evoked overflow, an effect abolished by (-)-sulpiride. Finally, bretylium (1 mmol/l), which blocks the release of dopamine, increased the evoked overflow. (-)-Sulpiride (1 mumol/l) lost its facilitatory effect in slices treated with bretylium. We conclude that the release of acetylcholine in rat nucleus accumbens, like its release in the nucleus caudatusputamen, is modulated through dopamine D2-receptors.(ABSTRACT TRUNCATED AT 250 WORDS)
为了研究大鼠伏隔核组织中乙酰胆碱的释放是否通过多巴胺受体进行调节,开展了相关切片实验。将切片用³H-胆碱预孵育,然后进行灌流,并以3Hz的频率电刺激两次,每次2分钟。在各个组中,电诱发的氚外流平均为组织中氚含量的2.9 - 3.9%。D2选择性激动剂喹吡罗(0.01 - 1μmol/L)使诱发的氚外流最大减少56%,该效应被D2选择性拮抗剂(-)-舒必利(1μmol/L)拮抗。D1选择性激动剂2,3,4,5-四氢-7,8-二羟基-1-苯基-1H-3-苯并氮杂卓(SKF 38393)仅在10μmol/L的高浓度下引起轻微下降。单独给予(-)-舒必利(0.1 - 10μmol/L)时,可适度增加诱发的氚外流。多巴胺摄取抑制剂诺米芬辛(10μmol/L)导致下降,在其存在下,(-)-舒必利产生的增加变得更加明显,最大可达149%。(+)-舒必利(0.1 - 1μmol/L)在诺米芬辛存在时未能改变诱发的氚外流。多巴胺释放剂(±)-苯丙胺(1μmol/L)也减少了诱发的外流,该效应被(-)-舒必利消除。最后,阻断多巴胺释放的溴苄铵(1mmol/L)增加了诱发的外流。在用溴苄铵处理的切片中,(-)-舒必利(1μmol/L)失去了其促进作用。我们得出结论,大鼠伏隔核中乙酰胆碱的释放,与其在尾状核壳核中的释放一样,是通过多巴胺D2受体进行调节的。(摘要截断于250字)